VRAX (Virax Biolabs Group) Current Accrued Expense : $0.13 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Current Accrued Expense?

Virax Biolabs Group's Current Accrued Expense for the quarter that ended in Mar. 2025 was $0.13 Mil.

Virax Biolabs Group's quarterly Current Accrued Expense increased from Mar. 2024 ($0.06 Mil) to Sep. 2024 ($0.12 Mil) and increased from Sep. 2024 ($0.12 Mil) to Mar. 2025 ($0.13 Mil).

Virax Biolabs Group's annual Current Accrued Expense declined from Mar. 2023 ($0.12 Mil) to Mar. 2024 ($0.06 Mil) but then increased from Mar. 2024 ($0.06 Mil) to Mar. 2025 ($0.13 Mil).

Virax Biolabs Group Current Accrued Expense Historical Data

The historical data trend for Virax Biolabs Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Current Accrued Expense Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Current Accrued Expense

Get a 7-Day Free Trial

0.28

0.27

0.12

0.06

0.13

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial						0.12	0.01	0.06	0.12	0.13

Virax Biolabs Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Virax Biolabs Group Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.